January 12, 2023
Premera, along with several other Blue Cross Blue Shield companies and the Blue Cross Blue Shield Association (BCBSA) are founding investors in Synergie Medication Collective, a new medication contracting organization.
Synergie’s goal is to lower costs and improve access to medications covered under the medical benefit. These are medications a medical professional gives in a healthcare setting, often via infusion or injection—many are very expensive treatments.
Synergie will contract with pharmaceutical manufacturers for medical rebates on these costly drugs to help lower the price. In addition, they’ll work with partners to find affordable solutions to drugs that don’t currently have a medical rebate. They also plan to partner with pharmaceutical manufacturers to ensure the quality outcomes match the high prices paid for the medications.
This founding group of BCBSA plans represents nearly 100 million Americans. The large scale means Synergie can achieve lower costs more efficiently than any one plan could do on its own.
More information is available on the Synergie website and recent press release.